feedback

Course Director

Edward B. Garon, MD, MS
Edward B. Garon, MD, MS

UCLA's Jonsson Comprehensive Cancer Center
David Geffen School of Medicine at UCLA
Los Angeles, California

Faculty

Jamie E. Chaft
Jamie E. Chaft, MD

Memorial Sloan Kettering Cancer Center
New York, New York

Matthew D. Hellmann
Matthew D. Hellmann, MD

Memorial Sloan Kettering Cancer Center
New York, New York

Accredited by

Medical Learning Institute, Inc.

Activity Details

Credit Types:CME / MOC / CE
Credit Amount:1.5 Credits
Release Date:2018-Nov-22
Expiration Date:2019-Nov-21
Estimated Time for Completion:90 minutes
Registration Required:No
Cost:Free of charge

Activity Description and Educational Objectives

In this activity, experts in lung cancer will explore the cutting-edge science, rational treatment strategies, new standards of care, and best practices related to the use of immunotherapies in the management of locally advanced or earlier stages of lung cancer.

Upon completion of this activity, participants will be able to:
  • Summarize the current immunotherapy landscape and state of the science in lung cancer, including key approvals and indications, as well as unanswered questions and unmet needs
  • Evaluate the latest data on efficacy and safety of immunotherapies and immune-based combinations in NSCLC throughout the disease continuum
  • Establish the optimal treatment approach involving immunotherapy for patients with stage III NSCLC and other earlier disease settings in the context of clinical practice and clinical trials
  • Determine the best immunotherapy-based treatment approaches for patients with metastatic NSCLC in the context of clinical practice and clinical trials

Target Audience

This activity has been designed to meet the educational needs of oncologists and other clinicians involved in the management of patients with lung cancer.

Nursing Education Purpose Statement

The purpose of this activity is to improve knowledge and competence of nurses concerning the evolving role of immunotherapies in lung cancer.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME/MOC/CE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/MOC/CE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: November 22, 2018 - November 21, 2019
Time to Complete: 90 minutes

Faculty and Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/MOC/CE activity during the past 12 months.

Course Director

Edward B. Garon, MD, MS
Director, Thoracic Oncology Program
Health Sciences Associate Professor
Department of Medicine
Division of Hematology-Oncology
UCLA's Jonsson Comprehensive Cancer Center
David Geffen School of Medicine at UCLA
Los Angeles, California

Edward B. Garon, MD, MS, has no financial interests/relationships or affiliations in relation to this activity.

Edward B. Garon, MD, MS, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: Immune checkpoint inhibitors as monotherapies or as part of combinations.

Faculty

Jamie E. Chaft, MD
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Jamie E. Chaft, MD, has a financial interest/relationship or affiliation in the form of:
Advisory Board for AstraZeneca; Bristol-Myers Squibb; Genentech, Inc.; and Merck & Co., Inc.
Other Financial or Material Support from Education talks with AstraZeneca.

Jamie E. Chaft, MD, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: Immune checkpoint inhibitors as monotherapies or as part of combinations.

Matthew D. Hellmann, MD
Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, New York

Matthew D. Hellmann, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for AstraZeneca; Bristol-Myers Squibb; Genentech, Inc./F. Hoffmann-La Roche Ltd; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; Mirati Therapeutics, Inc.; Nektar Therapeutics; Shattuck Labs; and Syndax Pharmaceuticals Inc.
Grant/Research Support from Bristol-Myers Squibb.

Matthew D. Hellmann, MD, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: Immune checkpoint inhibitors as monotherapies or as part of combinations.

CME Reviewer

Shaina Rozell, MD, MPH

Shaina Rozell, MD, MPH, has no financial interests/relationships or affiliations in relation to this activity.

Nurse Reviewer

Amita B. Patel, MSN, RN, AOCNP, NP-C

Amita B. Patel, MSN, RN, AOCNP, NP-C, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Kadrin Wilfong, MD
PVI, PeerView Institute for Medical Education

Kadrin Wilfong, MD, has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer

The information provided at this CME/MOC/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit, and Support

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement

MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Participation information will be shared with ABIM through the ACCME’s Program and Activity Reporting System (PARS). Individual or aggregated participant data may be shared with the funder of the activity.

Nurses

Medical Learning Institute, Inc.
Provider approved by the California Board of Registered Nursing, Provider Number 15106, for 1.5 contact hour(s).

Providership


This CME/MOC/CE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by an independent educational grant from AstraZeneca.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CME/MOC/CE Activity

PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.

Copyright © 2000-2018, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.